Marco G Patti1. 1. Department of Surgery, University of Chicago Pritzker School of Medicine, Chicago, Illinois.
Abstract
IMPORTANCE: Gastroesophageal reflux disease (GERD) is prevalent worldwide, particularly in developed countries. It is estimated that the prevalence of GERD in the United States is approximately 20% and that it is increasing because of the epidemic of obesity. OBJECTIVE: To review the pathophysiology, clinical presentation, diagnostic evaluation, and treatment of GERD. EVIDENCE REVIEW: A search of PubMed was conducted for the years spanning 1985 to 2015 and included the following terms: heartburn, regurgitation, dysphagia, gastroesophageal reflux disease, cough, aspiration, laryngitis, GERD, GORD, endoscopy, manometry, pH monitoring, proton pump inhibitors, open fundoplication, and laparoscopic fundoplication. Only articles in English were included. FINDINGS: Lifestyle modifications, proton pump inhibitors, and laparoscopic fundoplication are proven treatment modalities for GERD. Endoscopic procedures have not been proven as effective. A Roux-en-Y gastric bypass is the procedure of choice when GERD and morbid obesity coexist. CONCLUSIONS AND RELEVANCE: Gastroesophageal reflux disease is a highly prevalent disease. Once the diagnosis has been established, the best results are obtained by a multidisciplinary team with the goal of individualizing treatment for patients.
IMPORTANCE: Gastroesophageal reflux disease (GERD) is prevalent worldwide, particularly in developed countries. It is estimated that the prevalence of GERD in the United States is approximately 20% and that it is increasing because of the epidemic of obesity. OBJECTIVE: To review the pathophysiology, clinical presentation, diagnostic evaluation, and treatment of GERD. EVIDENCE REVIEW: A search of PubMed was conducted for the years spanning 1985 to 2015 and included the following terms: heartburn, regurgitation, dysphagia, gastroesophageal reflux disease, cough, aspiration, laryngitis, GERD, GORD, endoscopy, manometry, pH monitoring, proton pump inhibitors, open fundoplication, and laparoscopic fundoplication. Only articles in English were included. FINDINGS: Lifestyle modifications, proton pump inhibitors, and laparoscopic fundoplication are proven treatment modalities for GERD. Endoscopic procedures have not been proven as effective. A Roux-en-Y gastric bypass is the procedure of choice when GERD and morbid obesity coexist. CONCLUSIONS AND RELEVANCE: Gastroesophageal reflux disease is a highly prevalent disease. Once the diagnosis has been established, the best results are obtained by a multidisciplinary team with the goal of individualizing treatment for patients.
Authors: Daniel Skubleny; Noah J Switzer; Jerry Dang; Richdeep S Gill; Xinzhe Shi; Christopher de Gara; Daniel W Birch; Clarence Wong; Matthew M Hutter; Shahzeer Karmali Journal: Surg Endosc Date: 2016-12-15 Impact factor: 4.584
Authors: H Reza Zahiri; Adam S Weltz; Udai S Sibia; Neethi Paranji; Steven D Leydorf; George T Fantry; Adrian E Park Journal: Surg Endosc Date: 2017-05-10 Impact factor: 4.584
Authors: Kristy Kummerow Broman; Sharon E Phillips; Adil Faqih; Joan Kaiser; Richard A Pierce; Benjamin K Poulose; William O Richards; Kenneth W Sharp; Michael D Holzman Journal: Surg Endosc Date: 2017-10-18 Impact factor: 4.584
Authors: Kais A Rona; Jessica Reynolds; Katrin Schwameis; Joerg Zehetner; Kamran Samakar; Paul Oh; David Vong; Kulmeet Sandhu; Namir Katkhouda; Nikolai Bildzukewicz; John C Lipham Journal: Surg Endosc Date: 2016-08-23 Impact factor: 4.584
Authors: Janey S A Pratt; Allen Browne; Nancy T Browne; Matias Bruzoni; Megan Cohen; Ashish Desai; Thomas Inge; Bradley C Linden; Samer G Mattar; Marc Michalsky; David Podkameni; Kirk W Reichard; Fatima Cody Stanford; Meg H Zeller; Jeffrey Zitsman Journal: Surg Obes Relat Dis Date: 2018-03-23 Impact factor: 4.734
Authors: Janey S A Pratt; Sebastian S Roque; Ruben Valera; Kathryn S Czepiel; Deborah D Tsao; Fatima Cody Stanford Journal: Semin Pediatr Surg Date: 2020-01-20 Impact factor: 2.754
Authors: T Omari; F Connor; L McCall; L Ferris; S Ellison; B Hanson; R Abu-Assi; S Khurana; D Moore Journal: United European Gastroenterol J Date: 2018-03-08 Impact factor: 4.623